Tsoutsou PG - Search Results

1

The use of PET/CT in radiotherapy planning: contribution of deformable registration.

Delikgoz Soykut E, Ozsahin EM, Yukselen Guney Y, Aytac Arslan S, Derinalp Or O, Altundag MB, Ugurluer G, Tsoutsou PG. Delikgoz Soykut E, et al. Among authors: tsoutsou pg. Front Oncol. 2013 Apr 12;3:33. doi: 10.3389/fonc.2013.00033. eCollection 2013. Front Oncol. 2013. PMID: 23630662 Free PMC article. No abstract available.

2

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity.

Tsoutsou PG, Zaman K, Martin Lluesma S, Cagnon L, Kandalaft L, Vozenin MC. Tsoutsou PG, et al. Front Oncol. 2018 Dec 12;8:609. doi: 10.3389/fonc.2018.00609. eCollection 2018. Front Oncol. 2018. PMID: 30619749 Free PMC article. Review.

3

Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer.

Tsoutsou PG, Vozenin MC. Tsoutsou PG, et al. JAMA Oncol. 2019 Jan 1;5(1):111-112. doi: 10.1001/jamaoncol.2018.5077. JAMA Oncol. 2019. PMID: 30476960 No abstract available.

4

In Regard to Vasmel et al.

Tsoutsou PG. Tsoutsou PG. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1250-1251. doi: 10.1016/j.ijrobp.2021.01.038. Int J Radiat Oncol Biol Phys. 2021. PMID: 34171239 No abstract available.

5

How could breast cancer molecular features contribute to locoregional treatment decision making?

Tsoutsou PG, Vozenin MC, Durham AD, Bourhis J. Tsoutsou PG, et al. Crit Rev Oncol Hematol. 2017 Feb;110:43-48. doi: 10.1016/j.critrevonc.2016.12.006. Epub 2016 Dec 8. Crit Rev Oncol Hematol. 2017. PMID: 28109404 Review.

6

A need for biology-driven personalized radiotherapy in breast cancer.

Tsoutsou PG, Durham AD, Vozenin MC. Tsoutsou PG, et al. Breast Cancer Res Treat. 2018 Jan;167(2):603-604. doi: 10.1007/s10549-017-4522-z. Epub 2017 Sep 27. Breast Cancer Res Treat. 2018. PMID: 28952059 No abstract available.

7

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.

Matzinger O, Viertl D, Tsoutsou P, Kadi L, Rigotti S, Zanna C, Wiedemann N, Vozenin MC, Vuagniaux G, Bourhis J. Matzinger O, et al. Radiother Oncol. 2015 Sep;116(3):495-503. doi: 10.1016/j.radonc.2015.05.017. Epub 2015 Jun 18. Radiother Oncol. 2015. PMID: 26096848

8

TAT-RasGAP_317-326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death.

Tsoutsou P, Annibaldi A, Viertl D, Ollivier J, Buchegger F, Vozenin MC, Bourhis J, Widmann C, Matzinger O. Tsoutsou P, et al. Radiat Res. 2017 May;187(5):562-569. doi: 10.1667/RR14509.1. Epub 2017 Mar 21. Radiat Res. 2017. PMID: 28323576

9

Sex-Specific Differences in Toxicity Following Systemic Paclitaxel Treatment and Localized Cardiac Radiotherapy.

Chmielewski-Stivers N, Petit B, Ollivier J, Monceau V, Tsoutsou P, Quintela Pousa A, Lin X, Limoli C, Vozenin MC. Chmielewski-Stivers N, et al. Cancers (Basel). 2021 Aug 6;13(16):3973. doi: 10.3390/cancers13163973. Cancers (Basel). 2021. PMID: 34439129 Free PMC article.

10

Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

Santa Cruz O, Tsoutsou P, Castella C, Khanfir K, Anchisi S, Bouayed S, Matzinger O, Ozsahin M. Santa Cruz O, et al. Oncology. 2018;95(2):61-68. doi: 10.1159/000489217. Epub 2018 Jun 12. Oncology. 2018. PMID: 29895020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters